Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Howell

Showing results (181-190 of 339) with videos related to

Pageof 34
Sort By:
BMC Cancer|December 5, 2019
Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trialsMichelle Harvie, Mary Pegington, David French, et al.
Cell Cycle (Georgetown, Tex.)|July 23, 2011
Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumorsUbaldo E Martinez-Outschoorn, Zhao Lin, Casey Trimmer, et al.
The Lancet. Oncology|December 3, 2014
Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trialIvana Sestak, Shalini Singh, Jack Cuzick, et al.
BMC Nutrition|October 28, 2025
A randomised controlled trial of short-term Intermittent Energy Restriction [IER] versus Continuous Energy Restriction [CER] on body fat stores and measures of insulin resistance in women with obesity at increased risk of breast cancerMichelle Harvie, Pete Coe, Claire Higham, et al.
Journal of Medical Genetics|July 21, 2009
Breast cancer susceptibility variants alter risks in familial diseaseAyse Latif, Kristen D Hadfield, Stephen A Roberts, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancerLouise M Byrd, Andrew Shenton, Eamonn R Maher, et al.
Cancer|June 7, 2005
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trialsAnthony Howell, John Pippen, Richard M Elledge, et al.
Cell Cycle (Georgetown, Tex.)|December 22, 2012
Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metforminRosa Sanchez-Alvarez, Ubaldo E Martinez-Outschoorn, Rebecca Lamb, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2013
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriersD Gareth R Evans, Sarah L Ingham, Iain Buchan, et al.
Breast Cancer Research : BCR|March 29, 2008
Evaluation of the current knowledge limitations in breast cancer research: a gap analysisAlastair Thompson, Keith Brennan, Angela Cox, et al.
Pageof 34

Showing results (181-190 of 339) with videos related to

Sort By:
Pageof 34
BMC Cancer|December 5, 2019
Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trialsMichelle Harvie, Mary Pegington, David French, et al.
Cell Cycle (Georgetown, Tex.)|July 23, 2011
Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumorsUbaldo E Martinez-Outschoorn, Zhao Lin, Casey Trimmer, et al.
The Lancet. Oncology|December 3, 2014
Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trialIvana Sestak, Shalini Singh, Jack Cuzick, et al.
BMC Nutrition|October 28, 2025
A randomised controlled trial of short-term Intermittent Energy Restriction [IER] versus Continuous Energy Restriction [CER] on body fat stores and measures of insulin resistance in women with obesity at increased risk of breast cancerMichelle Harvie, Pete Coe, Claire Higham, et al.
Journal of Medical Genetics|July 21, 2009
Breast cancer susceptibility variants alter risks in familial diseaseAyse Latif, Kristen D Hadfield, Stephen A Roberts, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancerLouise M Byrd, Andrew Shenton, Eamonn R Maher, et al.
Cancer|June 7, 2005
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trialsAnthony Howell, John Pippen, Richard M Elledge, et al.
Cell Cycle (Georgetown, Tex.)|December 22, 2012
Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metforminRosa Sanchez-Alvarez, Ubaldo E Martinez-Outschoorn, Rebecca Lamb, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2013
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriersD Gareth R Evans, Sarah L Ingham, Iain Buchan, et al.
Breast Cancer Research : BCR|March 29, 2008
Evaluation of the current knowledge limitations in breast cancer research: a gap analysisAlastair Thompson, Keith Brennan, Angela Cox, et al.
Pageof 34